1. Baden, L.R., El Sahly, H.M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S.A., Rouphael, N., Creech, C.B., McGettigan, J., Khetan, S., Segall, N., Solis, J., Brosz, A., Fierro, C., Schwartz, H., Neuzil, K., Corey, L., Gilbert, P., Janes, H., Follmann, D., Marovich, M., Mascola, J., Polakowski, L., Ledgerwood, J., Graham, B.S., Bennett, H., Pajon, R., Knightly, C., Leav, B., Deng, W., Zhou, H., Han, S., Ivarsson, M., Miller, J., Zaks, T., 2021. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 384, 403–416. https://doi.org/10.1056/NEJMoa2035389.
2. Buckner, J.H., Chowell, G., Springborn, M.R., 2020. Optimal Dynamic Prioritization of Scarce COVID-19 Vaccines. MedRxiv Prepr. Serv. Health Sci. https://doi.org/10.1101/2020.09.22.20199174.
3. CEPI survey assesses potential COVID-19 vaccine manufacturing capacity [WWW Document], n.d. CEPI. URL https://cepi.net/news_cepi/cepi-survey-assesses-potential-covid-19-vaccine-manufacturing-capacity/ (accessed 3.5.21).Comirnaty : summary of product characteristics, n.d.
4. Cowling, B.J., Lim, W.W., Cobey, S., 2021. Fractionation of COVID-19 vaccine doses could extend limited supplies and reduce mortality. Nat. Med. https://doi.org/10.1038/s41591-021-01440-4.
5. Czarska-Thorley, D., 2021. Extra dose from vials of Comirnaty COVID-19 vaccine [WWW Document]. Eur. Med. Agency. URL https://www.ema.europa.eu/en/news/extra-dose-vials-comirnaty-covid-19-vaccine (accessed 2.21.21).